< Back to previous page
Researcher
Pablo BOTELLA LUCENA
- Keywords:Biomedical sciences (incl. biochemistry)
- Disciplines:Behavioural neuroscience, Neurological and neuromuscular diseases, Neurosciences not elsewhere classified, Pathophysiology
Affiliations
- Neurosciences (Department)
Member
From1 Jan 2020 → Today - Neurosciences (Research group)
Member
From1 Jan 2020 → Today - Biomedical Research Institute (Research institute)
Member
From16 Nov 2018 → Today - Faculty of Medicine and Life Sciences (Faculty)
Member
From16 Nov 2018 → Today - Physiology - Biochemistry - Immunology (Department)
Member
From16 Nov 2018 → 31 Dec 2019 - Physiology (Research group)
Member
From16 Nov 2018 → 31 Dec 2019
Publications
1 - 4 of 4
- Targeting Alzheimer’s Disease progression along the Amyloid/ Tau/Neurodegeneration axis: NLRP3-inflammasome-based halting and early prevention strategies(2023)
Authors: Pablo BOTELLA LUCENA, Ilse DEWACHTER
Number of pages: 220 - Motility phenotype in a zebrafish vmat2 mutant(2022)
Authors: Hildur Soley Sveinsdottir, Amanda Decker, Christian Christensen, Pablo BOTELLA LUCENA, Haraldur Porsteinsson, Elena Richert, Valerie Helene Maier, Robert Cornell, Karl Aegir Karlsson, Stephan C.F. Neuhauss
- Blood-based A beta 42 increases in the earliest pre-pathological stage before decreasing with progressive amyloid pathology in preclinical models and human subjects: opening new avenues for prevention(2022)
Authors: Pablo BOTELLA LUCENA, Sarah VANHERLE, Chritica LODDER, Manu GUTIERREZ DE RAVE, Ilie Cosmin STANCU, Ivo LAMBRICHTS, Riet Vangheluwe, Rose BRUFFAERTS, Ilse DEWACHTER
Pages: 489 - 508 - CSF1R inhibition rescues tau pathology and neurodegeneration in an A/T/N model with combined AD pathologies, while preserving plaque associated microglia(2021)
Authors: Chritica LODDER, I Scheyltjens, Ilie Cosmin STANCU, Pablo BOTELLA LUCENA, Manu GUTIERREZ DE RAVE, Sarah VANHERLE, Tim VANMIERLO, Niels CREMERS, Hannah VANRUSSELT, Bert BRONE, et al.